Preview

Neurology, Neuropsychiatry, Psychosomatics

Advanced search

Search


Order results by:     
 
Issue Title
 
Vol 9, No 3 (2017) Clinical results of and prospects for the use of controlled-release antiepileptic drugs: a new once-daily levetiracetam formulation Abstract  similar documents
P. N. Vlasov
"... . The emergence of a new sustained-release levetiracetam formulation in neurologists' practice greatly enhances ..."
 
Vol 4, No 1 (2012) Generalized epilepsies: current conceptions and therapeutic approaches Abstract  similar documents
L R Zenkov
"... , dosage form, side effects, and cost. Among broad-spectrum agents (valproate (VPA), levetiracetam ..."
 
Vol 9, No 1S (2017): SPECIAL ISSUE: EPILEPSY The efficacy and safety of valproic acid medications with controlled active ingredient release in adults in real clinical practice from the position of pharmacokinetic and pharmacogenetic approaches Abstract  similar documents
P. N. Vlasov, N. V. Orekhova, M. V. Antonyuk, N. V. Filatova, N. A. Schnaider, D. V. Dmitrenko, S. N. Zobova, I. E. Poverennova, A. V. Yakunina, V. A. Kalinin, S. K. Zyryanov, I. F. Tishchenkova
"... Objective: to analyze the efficacy and tolerability of sustained-release sodium valproate (SV ..."
 
Vol 4, No 1S (2012): Special issue "Epilepsy" New antiepileptic drugs, cost-efficacy analysis Abstract  similar documents
P. N. Vlasov, N. V. Orekhova, T. I. Konovalova
"... and cost-effectiveness of its therapy with the new antiepileptic drugs (AED): levetiracetam, lamotrigine ..."
 
Vol 4, No 1S (2012): Special issue "Epilepsy" Long-term levetiracetam monotherapy for partial epilepsy in adults Abstract  similar documents
P. N. Vlasov, V. A. Karlov, E. G. Komelkova, Z. S. Shakhabasova
"... The paper analyzes the efficiency of 3-year monotherapy with levetiracetam (LTC) (keppra) in 143 ..."
 
Vol 11, No 4 (2019) Genetic risk factors for behavioral adverse reactions in epileptic patients taking levetiracetam Abstract  similar documents
A. A. Usoltseva, D. V. Dmitrenko, S. N. Zobova, E. N. Bochanova, N. A. Shnayder
"... Levetiracetam (LEV) is an effective antiepileptic drug. Nevertheless, when the drug is used, its ..."
 
Online-first GENETIC RISK FACTORS FOR THE DEVELOPMENT OF BEHAVIORAL ADVERSE DRUG REACTIONS IN PATIENTS WITH EPILEPSY TAKING LEVETIRACETAM Abstract  similar documents
A. A. Usoltseva, D. V. Dmitrenko, S. N. Zobova, E. N. Bochanova, N. A. Shnayder
"... Levetiracetam (LEV) is a highly effective antiepileptic drug (AED). However, unwanted behavioral ..."
 
Vol 7, No 1S (2015): Special issue "Epilepsy" Efficacy of generic levetiracetam (epiterra) in monotherapy for epilepsy in adult patients: preliminary results Abstract  similar documents
V. A. Karlov, P. N. Vlasov, I. A. Zhidkova
"... Objective: to evaluate the efficacy and tolerability of levetiracetam (LEV) (epiterra, TEVA ..."
 
Vol 10, No 1S (2018): СПЕЦВЫПУСК: ЭПИЛЕПСИЯ An open-label prospective clinical study of the efficacy and tolerability of brand-name and generic levetiracetam in the monotherapy of focal epilepsy in adults Abstract  similar documents
V. A. Karlov, P. N. Vlasov, I. A. Zhidkova
"... with levetiracetam (LEV), a brand-name drug (bLEV; Keppra, UCB Pharma, Belgium) and its generic (gLEV;  Epiterra ..."
 
No 1S (2016): Status epilepticus: Analysis of refractory cases Abstract  similar documents
B. P. Gladov, O. A. Podgornaya, P. N. Vlasov
"... antiepileptic drugs (AEDs), such as diazepam (DZP); valproic acid (VPA); levetiracetam; and lacosamide ..."
 
Vol 4, No 1 (2012) Sustained-release pramipexole in the treatment of Parkinson’s disease Abstract  similar documents
Natalia Vladimirovna Fedorova
"... increases the adherence of a patient with PD to regular treatment. Two (extended- and immediate-release ..."
 
Vol 5, No 1 (2013) Practical aspects of the use of extended-release ropinirole (requip modutab) in the treatment of Parkinson’s disease Abstract  similar documents
Oleg Semenovich Levin, V K Datiyeva
"... Extended-release ropinirole is a new formulation of the well-known nonergolinic D2/D3 dopamine ..."
 
Vol 6, No 1S (2014): Special issue "Epilepsy" The Clinical and Neurophysiological Features of Epileptic Syndromes Associated with Benign Focal Epileptiform Discharges of Childhood Abstract  similar documents
N. A. Ermolaenko, I. A. Buchneva, E. I. Zakharova
"... % even if they have no epileptic seizures. Duo-therapy with valproate and ethosuximide or levetiracetam ..."
 
Vol 6, No 1S (2014): Special issue "Epilepsy" Intravenous Antiepileptic Drugs in Russia Abstract  similar documents
P. N. Vlasov
"... (Vimpat), and levetiracetam (Keppra) – into the Russian market has significantly broadened ..."
 
Vol 8, No 2 (2016) Effectiveness of prolonged-release melatonin in Improving Quality of Sleep in Patients Aged 55 or Over Abstract  similar documents
G. V. Kovrov, M. V. Agaltsov, Z. N. Sukmarova
"... Objective: to evaluate the efficacy of prolonged-release melatonin used in routine practice ..."
 
Vol 2, No 3 (2010) Russian observational study of the efficacy and tolerability of depakine chrono as first-line monotherapy for focal epilepsy Abstract  similar documents
E. D. Belousova
"... Objective: to evaluate the efficacy and tolerability of sustained-release sodium valproate sodium ..."
 
Vol 2, No 2 (2010) Antiaggregant therapy in neurological practice: objectives and possibilities Abstract  similar documents
E. V. Portnyagina, A. F. Portnyagin
 
Vol 5, No 2 (2013) Locomotor therapy with extended-release crystalline glucocorticoids Abstract  similar documents
Vladimir Vasilyevich Badokin
 
Vol 7, No 3 (2015) Experience with sustained-release melatonin for the treatment of sleep disorders in depression Abstract  similar documents
Svetlana Vladimirovna Prokhorova, T. N. Maksimova
"... . Sustained-release melatonin is a synthetic analogue of the endogenous human pineal hormone melatonin ..."
 
Vol 6, No 3 (2014) Current therapy for Parkinson's disease Abstract  similar documents
A. V. Obukhova
"... . A novel extended-release formulation of pramipexole is considered separately. Both immediate- and extended ..."
 
Vol 5, No 1S (2013): Special issue "Epilepsy" Epilepsy and autism: The authors’ study data Abstract  similar documents
K. V. Voronkova, O. A. Pylayeva, A. A. Kholin, G. S. Golosnaya, T. V. Ananyeva, A. S. Petrukhin
"... of therapy in the children followed up. Levetiracetam, etosuximide, and other antiepileptic medications were ..."
 
Vol 4, No 2 (2012) Therapy for back pain syndrome Abstract  similar documents
E Yu Solovyeva
"... -release enteric-coated granules and individual immediate-release granules of vitamins B 1 ..."
 
Vol 4, No 3 (2012) Clinical experience with requip modutab Abstract  similar documents
Denis Valeryevich Zakharov, V A Mikhailov
"... dyskinesias. Controlled-release DRAs are of particular interest. The results of using requip modutab in PD ..."
 
Vol 4, No 2 (2012) Impact of antiepileptic therapy on the course of affective disorders in women with epilepsy Abstract  similar documents
E V Zheleznova, I L Medvedev, V V Kalinin
"... Проведен анализ влияния противоэпилептических препаратов (ПЭП) на аффективные расстройства у женщин ..."
 
Vol 9, No 1S (2017): SPECIAL ISSUE: EPILEPSY Rationale for mono- versus polytherapy with antiepileptic drugs for patients with epilepsy Abstract  similar documents
L. V. Lipatova, T. V. Kapustina
"... после неудачи монотерапии первым противоэпилептическим препаратом (ПЭП). При выборе альтернативной ..."
 
No 1S (2016): Molecular mechanisms responsible for the impact of antiepileptic therapy on bone mineral density of epileptic patients Abstract  similar documents
I. A. Zhidkova, T. V. Kaznacheeva, E. Yu. Demidova, V. V. Berseneva
"... Противоэпилептические препараты (ПЭП) могут оказывать неблагоприятное влияние на костную ткань ..."
 
Vol 5, No 1S (2013): Special issue "Epilepsy" Efficiency and tolerance of sustained-release valproate sodium (Depakine®ChronosphereТМ) as the drug of the first choice in the treatment of adult epilepsy Abstract  similar documents
E. D. Belousova, G. N. Avakyan
 
Vol 4, No 2 (2012) Sleep and memory problems: acetylcholine in some neurodegenerative diseases, use of an extended-release formulation of galantamine Abstract  similar documents
I V Litvinenko
 
Vol 4, No 2 (2012) Capacities of the dopamine receptor agonist pramipexole in the treatment of patients with Parkinson’s disease Abstract  similar documents
S N Illarioshkin
"... release formulation: the administration of the drug considerably reduces the dose titration period ..."
 
Vol 9, No 1S (2017): SPECIAL ISSUE: EPILEPSY Russian Register of Pregnancy and Epilepsy Abstract  similar documents
D. V. Dmitrenko, N. A. Schnaider, A. N. Goroshkin, A. I. Tomilina, P. N. Vlasov, M. R. Sapronova
"... Применение противоэпилептических препаратов (ПЭП) во время беременности связано с повышенным ..."
 
Vol 9, No 2 (2017) Chemoreactomic analysis of thiamine disulfide, thiamine hydrochloride, and benfotiamine molecules Abstract  similar documents
O. A. Gromova, I. Yu. Torshin, L. V. Stakhovskaya, L. E. Fedotova
"... acetylcholine release to a large extent than benfotiamine. These molecular effects are consistent ..."
 
Vol 1, No 3-4 (2009) RUSSIAN OBSERVATIONAL SURVEY OF THE SHORT-TERM EFFICACY AND TOLERABILITY OF SUSTAINED-RELEASE SODIUM VALPROATE (DEPAKINE CHRONOSPHERA®) AS A FIRST-LINE DRUG IN THE TREATMENT OF EPILEPSY Abstract  similar documents
E. D. Belousova, A. Yu. Ermakov
"... Objective. To have additional data on the short-term safety and efficacy of sustained-release ..."
 
Vol 7, No 3 (2015) Efficiency of epilepsy treatment in the Moscow Region under the present-day conditions of drug provision Abstract  similar documents
Irina Gennadyevna Rudakova, Yu. A. Belova
"... противоэпилептических препаратов (ПЭП) в соответствии с их международным непатентованным наименованием. Пациенты и ..."
 
Vol 9, No 1S (2017): SPECIAL ISSUE: EPILEPSY Analysis of hormone-dependent pathology in female patients with juvenile myoclonic epilepsy Abstract  similar documents
D. V. Anisimova, R. V. Magzhanov, P. N. Vlasov, V. A. Petrukhin, E. B. Tsevtsivadze, S. R. Nurmukhametova
"... препараты (ПЭП) на протяжении года и более в режиме моно- и битерапии. Результаты. У 66,7% пациенток ..."
 
Vol 2, No 4 (2010) Gastrointestinal events during treatment with nonsteroidal anti-inflammatory drugs (according to the data of the CONDOR study) Abstract  similar documents
V. V. Alekseev
"... receiving celecoxib in a dose of 200 mg twice daily or sustained-release diclofenac 75 mg twice daily ..."
 
Vol 4, No 1S (2012): Special issue "Epilepsy" Hormone-dependent abnormality of the female sexual sphere during monotherapy with valproate, carbamazepine, and lamotrigine Abstract  similar documents
P. N. Vlasov, O. F. Serova, D. V. Dranko, N. V. Filatova, Z. S. Shakhabasova
"... лет), получавших монотерапию противоэпилептическими препаратами (ПЭП) не менее года. 40 из этих ..."
 
Vol 5, No 1S (2013): Special issue "Epilepsy" The effect of antiepileptic drugs on cognitive functions Abstract  similar documents
A. S. Kotov
"... , valproates, oxcarbazepine, topiramate, lamotrigine, and levetiracetam in terms of their action ..."
 
Vol 10, No 1S (2018): СПЕЦВЫПУСК: ЭПИЛЕПСИЯ Unverricht-Lundborg disease in an adult female patient: a clinical case Abstract  similar documents
V. A. Karlov, I. A. Zhidkova, E. Yu. Mishina, P. N. Vlasov, N. V. Margosyuk, L. P. Tingaeva, E. M. Perepelova, V. A. Perepelov, B. P. Gladov, S. A. Trukhanov
"... contribution to the  achievement of certain success of currently available antiepileptic drugs, levetiracetam ..."
 
Vol 3, No 2 (2011) The hemostatic system in neonates whose mothers took antiepileptic agents during pregnancy Abstract  similar documents
V. A. Petrukhin, V. L. Grishin, A. P. Mel'nikov, P. N. Vlasov, G. R. Drozhzhina
"... препараты (ПЭП). Пациенты и методы. Проведено наблюдение за 187 новорожденными. Среди препаратов, которые ..."
 
No 1S (2016): The pattern of female genital hormonal disease in juvenile myoclonic epilepsy Abstract  similar documents
D. V. Anisimova, R. V. Magzhanov, P. N. Vlasov, V. A. Petrukhin, E. B. Tsevtsevadze, S. R. Nurmukhametova, F. Yu. Garifullina
"... противоэпилептические препараты (ПЭП) на протяжении более года в режиме монои битерапии. Для сравнения показателей в ..."
 
Vol 2, No 2 (2010) Neuropathology of epileptic encephalopathies and non-paroxysmal epileptic disorders and principles of their treatment Abstract  similar documents
L. R. Zenkov
"... epileptiform activity (valproate, levetiracetam, and lamotrigine) as a first-choice drug and caution when ..."
 
Vol 9, No 1S (2017): SPECIAL ISSUE: EPILEPSY Cognitive and emotional changes in patients with juvenile myoclonic epilepsy Abstract  similar documents
R. V. Magzhanov, D. V. Anisimova, P. N. Vlasov, V. A. Petrukhin, E. B. Tsevtsivadze, S. R. Nurmukhametova
"... фона, принимаемых противоэпилептических препаратов (ПЭП) и течения заболевания в генезе выявленных ..."
 
Vol 10, No 1S (2018): СПЕЦВЫПУСК: ЭПИЛЕПСИЯ Additional sanogenetic effect of topiramate in the treatment of epilepsy in women of childbearing age Abstract  similar documents
N. V. Filatova, N. V. Orekhova, P. N. Vlasov
"... (ПЭП) с менструальным циклом, избыточной массой тела и репродуктивными расстройствами у женщин. В связи ..."
 
Vol 7, No 3 (2015) Therapy for epilepsy in women: Additional sanogenetic effect caused by the intake of topiramate Abstract  similar documents
P. N. Vlasov, N. V. Orekhova, N. V. Filatova
"... , преимущественно получавших комбинированную терапию 2 противоэпилептическими препаратами (ПЭП). У 82,8% пациенток ..."
 
Vol 9, No 1S (2017): SPECIAL ISSUE: EPILEPSY Mechanisms of valproate-induced teratogenesis Abstract  similar documents
D. V. Dmitrenko, N. A. Shnaider, I. G. Strotskaya, A. S. Kichkaylo, S. N. Zobova
"... Риски, связанные с внутриутробным влиянием противоэпилептических препаратов (ПЭП), имеют большое ..."
 
Vol 4, No 2 (2012) Artra is a model of combination symptom-modifying therapy for osteoarthrosis and intervertebral osteochondrosis Abstract  similar documents
V V Badokin
"... The paper gives an update on therapy for osteoarthrosis (OA). Symptomatic sustained-release drugs ..."
 
Vol 5, No 1S (2013): Special issue "Epilepsy" Effect of drug formulation on the treatment of epilepsy Abstract  similar documents
S. G. Burd
"... on therapy efficiency, safety, and compliance in epileptic patients. Switching from sustained-release ..."
 
Vol 7, No 1S (2015): Special issue "Epilepsy" Use of valproates in women of childbearing age and pregnant women with epilepsy Abstract  similar documents
P. N. Vlasov
"... effective daily dose and sustained-release formulations.  ..."
 
Vol 10, No 4 (2018) Use of valproate and carbamazepine in the therapy of epilepsy (guidelines for the practitioner) Abstract  similar documents
P. N. Vlasov
"... -release formulations of VA and CBZ remain the drugs of first choice for many types of epilepsy. CBZ ..."
 
No 1S (2016): Clinical and electroencephalographic characteristics of chronic tic disorders in children and adolescents Abstract  similar documents
N. A. Ermolenko, E. I. Zakharova, I. A. Buchneva
"... with antiepileptic drugs (extended-release valproic acid) was effective and safe in both epileptic seizures ..."
 
1 - 50 of 50 Items

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default articles containing any term in the query are returned (i.e., OR is implied)
  • Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
  • Combine multiple words with AND to find articles containing all terms; e.g., education AND research
  • Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
  • Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)